Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
CSL Behring seeks a Director, US Business Analytics to advise the US Marketing Leadership Team, shaping portfolio, investment and growth decisions with data-driven recommendations. You will lead analytics priorities across HAE and Ig portfolios, supporting more than $5B in annual revenue.
You’ll manage a team delivering market insights, KPI dashboards, and performance indicators, partnering with US VP Marketing to translate data into strategic guidance for senior leadership.
The Director, US Business Analytics serves as a strategic analytics advisor to the US Marketing Leadership Team, influencing portfolio, investment, and growth decisions through data-driven recommendations. Accountable for defining analytics priorities and operating plans across the HAE and Immunoglobulin portfolio to support commercial strategy and business performance objectives. Lead and develop innovative business analytics tools to analyze and advise on complex business problems and issues across CSL (Behring & Vifor) with a focus on the HAE and Ig US portfolio of products contributing more than $5B in annual revenue. Operate as a business partner to US VP Marketing and the US Marketing leadership team by leading and owning the provision of analysis to provide quantitative market, competitor and brand insights. Manage team responsible for all business analytics in support of CSL inline portfolio products with a focus on the HAE and Ig and late-stage pre-launch development products. Drive innovation in business analytics deployment, data science and actionable insights. Contribute to portfolio and brand strategy development through metrics, KPI dashboards and performance indicators. Apply strong business acumen to synthesize quantitative and qualitative information into actionable recommendations.
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/ .
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL .
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement .